BUSINESS

Glenmark Pharma gets USFDA nod for Icatibant injection
IANS -
The injection is the generic version of Firazyr Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe, of Shire Human Genetic Therapies, Inc. According to Glenmark, this is the company's first synthetic decapeptide injectable approval and will be manufactured in their North American manufacturing facility based in Monroe, North Carolina.
Equity indices in green, banking stocks rise
IANS -
Around 10.50 a.m., Sensex was trading at 50,681.29, higher by 140.81 points or 0.28 per cent from its previous close of 50,540.48. It opened at 50,727.28 and has touched an intra-day high of 50,855.32 and a low of 50,465.90 points
JSW Steel calls reports of interest in Liberty Steel assets 'misleading'
IANS -
In a regulatory filing, the company said: "It is hereby clarified that such reports stating about the Company's interest in bidding/buying Liberty Steel's assets are not only speculative but also misleading and mischievous." Recent media reports suggested that JSW Steel is considering a bid to buy Liberty Steel's assets in the UK.
'False': Govt on reports PSBs withdrawing funds from abroad due to Cairn
IANS -
"Condemning all such source-based reports as false, the Government of India said that these are totally incorrect reports which were not based on true facts. Certain vested parties appear to have orchestrated such misleading reporting, which often relies upon unnamed sources and presents a lopsided picture of factual and legal developments in the case," said an official statement.
Equities to bounce on reopening hopes, declining Covid trend
IANS -
"Partial lifting of lockdown will raise hopes of early resumption of economic activities across the country, though gradually. The second Covid wave seems to be coming to an end over the next couple of weeks. This expectation has lifted sentiments in the equity markets," said Deepak Jasani- Head of Retail Research at HDFC Securities.
Guess what's keeping Indian space startups busy during lockdown
IANS -
They tell you that their earlier plans were affected by the Covid-19 lockdowns, but they hope their rockets and satellites would be set for lift-off in a year's time. Two private rocket makers, Skyroot Aerospace and Agnikul Cosmos, recently announced raising $11 million each. After that, the Covid-19 second wave swept the country, resulting in lockdowns and mobility restrictions
Samsung Biologics signs vaccine production deal with Moderna
IANS -
The two sides signed the contract on Saturday during a South Korea-U.S. vaccine partnership event held in Washington, DC, with President Moon Jae-in attendance, reports Yonhap news agency. Also present were John Rim, CEO of Samsung Biologics, and his Moderna counterpart Stephane Bancel, along with Stanley Erck, CEO of Novavax, another American vaccine production company.
Volatile yet lucrative, Bitcoin becomes Indians' dream investment
IANS -
While the short volatile period has widely been touted as a course correction (one Bitcoin is currently hovering around $37,000 after touching a record high of nearly $60,000 just a couple of weeks ago), industry experts are of the view that staying invested and thinking long-term is the thumb rule to follow for crypto investors in the country.
Start-up business to deliver necessities at the doorstep
IANS -
'Pick up and drop facility' has become an essential service for consumers all across the country. The service allows one to deliver or receive anything, be it lunch boxes, documents, laundry, items for repair, shoes, stationery and other materials from one location to another from anywhere in their city.
FMCG stocks significantly outperformed market over 20 years
IANS -
As per research by Jefferies, over the last two decades, while Nifty has returned 11.4 per cent Cagr, the market-cap-weighted performance for eight FMCG companies (HUL, ITC, Nestle, Britannia, Dabur, Marico, GCPL, Colgate) stood at 14.2 per cent Cagr. In absolute terms, while Nifty is up 10x in 20+ years, FMCG is up c.17x over the same period.
Advertisement